GlassScriptPhysician profile
Ziad Melhem
NPI 1407926017
$5,256.50
in general payments reported to CMS, 2019-2025
43 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $498 · 2021: $1,556 · 2022: $673 · 2023: $837 · 2024: $740 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833 · Entertainment: $13.54 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.26 |
| Entertainment | $13.54 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,071.12 | 2019-2025 | |
| Medtronic, INC. | $550.00 | 2021 | |
| Sumitomo Pharma America, INC. | $462.34 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $364.92 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $308.12 | 2021-2024 | |
| Baxter Healthcare | $214.72 | 2021-2024 | Perclot, Floseal |
| Exeltis, USA INC. | $214.45 | 2019-2025 | Slynd, Tyblume |
| Myovant Sciences INC. | $207.87 | 2021-2022 | |
| Lupin INC. | $171.55 | 2019-2021 | |
| Hologic Sales and Service, LLC | $141.04 | 2019-2024 | Acessa Provu System, Aptima, Myosure Tissue Removal Device |
| Agile Therapeutics, INC. | $124.20 | 2021-2023 | Twirla |
| Shield Therapeutics INC | $122.56 | 2023-2025 | Accrufer |
| Novo Nordisk INC | $121.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Millicent US INC | $101.40 | 2020-2025 | Femlyv, Intrarosa, Femring |
| Avion Pharmaceuticals | $97.06 | 2019-2023 | Balcoltra |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $93.23 | 2023 | Desara |
| Therapeuticsmd, INC. | $78.72 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $77.67 | 2019-2023 | Gardasil 9 |
| Allergan, INC. | $72.79 | 2019-2020 | |
| Pfizer INC. | $60.02 | 2024 | |
| Organon LLC | $58.74 | 2021-2025 | Jada System |
| Aspira Women'S Health INC | $55.57 | 2019-2024 | Ova1 |
| Dexcom, INC. | $49.10 | 2024-2025 | Dexcom G6 Transmitter |
| Pacira Pharmaceuticals Incorporated | $40.01 | 2019-2021 | |
| Coopersurgical, INC. | $39.63 | 2019-2023 | Endosee, Advincula Delineator Uterine Manipulator |
| Gynesonics, INC. | $36.73 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Intra-Sana Laboratories | $32.09 | 2024-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Lilly USA, LLC | $31.93 | 2020-2024 | Jardiance, Zepbound |
| Medicem INC. | $26.94 | 2020-2021 | |
| Mycovia Pharmaceuticals, INC. | $23.71 | 2023 | Vivjoa |
| Olympus America INC. | $22.23 | 2019 | |
| Daiichi Sankyo INC. | $21.56 | 2021 | |
| Avanos Medical | $18.37 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.34 | 2019 | |
| Genentech USA, INC. | $16.27 | 2020 | |
| Ethicon US, LLC | $15.67 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.18 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Kesin Pharma Corporation | $15.00 | 2023 | Likmez |
| Meditrina | $14.54 | 2022 | |
| Argentum Medical | $13.54 | 2025 | |
| Innovation Technologies INC | $13.13 | 2024 | Irrisept |
| Scynexis, INC. | $12.99 | 2022 | |
| Renovia INC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Melhem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.